EKOS™ Endovascular System
EKOS Endovascular System - Ultrasound-Assisted Catheter-Directed Thrombolysis
EKOS was the first interventional device indicated for the treatment of pulmonary embolism. EKOS is used for the infusion of physician-specified fluids, including thrombolytics, into the peripheral vasculature. EKOS' ultrasound technology accelerates drug dispersion, requiring less lytic agent.
Key Resources
Product Description
Ultrasonic Core Technology
- Minimally invasive, 15-minute procedure that is quick to perform
- Lytic agent: as low as 8 mg tPA used1
- Ultrasonic waves accelerate clot dissolution by unwinding and thinning fibrin strands to expose more drug receptor sites; acoustic streaming drives the drug deeper into the clot for safe dissolution
Reimbursement Information
- Tapson V et al. A randomized trial of the optimum duration of acoustic pulse thrombolysis procedure in acute intermediate-risk pulmonary embolism. JACC: Cardiovascular Interventions 2018; 11(14):1401-1410.